Identification of SPHK1 as a Therapeutic Target and Marker of Poor Prognosis in Cholangiocarcinoma

Oncotarget - United States
doi 10.18632/oncotarget.4335
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Pyruvate Kinase M2 Is a Poor Prognostic Marker of and a Therapeutic Target in Ovarian Cancer

PLoS ONE
Multidisciplinary
2017English

RETRACTED: Proteomics-Based Identification of Α-Enolase as a Potential Prognostic Marker in Cholangiocarcinoma

Clinical Biochemistry
MedicineClinical Biochemistry
2012English

Clinical Importance of S100A9 in Osteosarcoma Development and as a Diagnostic Marker and Therapeutic Target

Bioengineered
Applied MicrobiologyBiotechnologyMedicineBioengineering
2019English

Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer

PLoS ONE
Multidisciplinary
2015English

Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer

PLoS ONE
Multidisciplinary
2020English

623 CRD-BP as a Potential Prognostic Marker and Therapeutic Target in Melanoma

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2016English

Identification of Glycogen Synthase Kinase 3α as a Therapeutic Target in Melanoma

Pigment Cell and Melanoma Research
BiochemistryDermatologyOncologyGeneticsMolecular Biology
2013English

Genomic Analysis Reveals RhoC as a Potential Marker in Hepatocellular Carcinoma With Poor Prognosis

British Journal of Cancer
Cancer ResearchOncology
2004English

SPHK1 Is a Novel Target of Metformin in Ovarian Cancer

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy